Elsevier

Kidney International

Volume 85, Issue 4, April 2014, Pages 723-727
Kidney International

Editorial
Is a decline in estimated GFR an appropriate surrogate end point for renoprotection drug trials?

https://doi.org/10.1038/ki.2013.506Get rights and content
Under an Elsevier user license
open archive

Cited by (0)

The authors declared no competing interests.